CVS Health Confirms Tom Cowhey As New CFO

RTTNews | 355 dni temu
CVS Health Confirms Tom Cowhey As New CFO

(RTTNews) - CVS Health (CVS) announced Friday that Senior Vice President of Corporate Finance and interim CFO, Tom Cowhey, has been formally appointed the company's next CFO.

Cowhey succeeds Shawn Guertin, who will be stepping down from his roles due to family health reasons and will remain on personal leave and will leave the company on May 31, 2024.

Cowhey joined CVS Health in February of 2022. He previously served as CFO of Surgery Partners Inc., and before that spent more than a decade at Aetna in various strategy and finance roles.

Since joining CVS Health, he has overseen investor relations, corporate development, treasury, and finance operations, working closely with Lynch and the Executive Leadership Team to manage the company's overall financial strategy.

The company also said CEO of Oak Street Health and interim lead of Health Care Delivery, Mike Pykosz, has been formally appointed President of Health Care Delivery.

read more
CVS Health Reportedly Mulls Breakup, To Cut 2,900 Jobs

CVS Health Reportedly Mulls Breakup, To Cut 2,900 Jobs

CVS Health Corp. is conducting a strategic review of options including a possible breakup amid issues from its drugstore chain and Aetna health insurance arm, reports said citing person familiar with the matter. The company also plans to reduce its workforce by less than 1 percent, which would affect around 2,900 employees, as part of its cost-cutting efforts.
RTTNews | 85 dni temu
CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines

CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines

CVS Health Corp. announced Wednesday the availability of updated 2024-2025 COVID-19 vaccines and flu vaccines at CVS Pharmacy and MinuteClinic locations across the United States. The U.S. Food and Drug Administration recently approved and granted emergency use authorization or EUA for updated Covid vaccines (2024-2025 formula) from Pfizer Inc. and ModernaTX Inc. for use against currently...
RTTNews | 119 dni temu
CVS Health Slashes FY24 Outlook; Stock Down 11% - Update

CVS Health Slashes FY24 Outlook; Stock Down 11% - Update

While reporting financial results for the first quarter on Wednesday, CVS Health (CVS) slashed its earnings and adjusted earnings guidance for the full-year 2024, reflecting the potential for continued elevated medical cost trends in the remainder of 2024.
RTTNews | 238 dni temu
P&G Recalls 8.2 Mln Defective Laundry Detergent Packets

P&G Recalls 8.2 Mln Defective Laundry Detergent Packets

Consumer goods giant Procter & Gamble Co. has called back around 8.2 million defective bags of Tide, Gain, Ace and Ariel laundry detergent packets distributed in the United States citing risk of serious injury, the U.S. Consumer Product Safety Commission announced. In addition, about 56,741 were sold in Canada. According to the agency, the outer packaging meant to prevent access to the contents...
RTTNews | 261 dni temu
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews | 296 dni temu
CVS Health Lowers FY24 Outlook - Update

CVS Health Lowers FY24 Outlook - Update

While reporting financial results for the fourth quarter on Wednesday, CVS Health (CVS) lowered its earnings and adjusted earnings guidance for the full-year 2024.
RTTNews | 322 dni temu
CVS To Remove Some Cold, Cough Medicines With Phenylephrine

CVS To Remove Some Cold, Cough Medicines With Phenylephrine

CVS Health is removing certain over-the-counter or OTC cold and cough products with phenylephrine as the only active ingredient from its Pharmacy stores, reports said. The decision follows the U.S. Food and Drug Administration Advisory Committee's position on oral phenylephrine or PE.
RTTNews | 432 dni temu
FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

The U.S. Food and Drug Administration has warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. The agency has issued warning letters to these companies as part of its ongoing effort to protect Americans from potentially harmful ophthalmic products.
RTTNews | 469 dni temu